Educational use only — not investment advice. "Undervalued / fairly valued / overvalued" and every risk score reflect our models vs. price, which can be wrong or based on stale or incomplete data. Always review the company's own financials and SEC filings, and consult a licensed advisor, before acting.
PCYO
Deeply overvalued
PURE CYCLE CORP
Price$11.11
Model IV$4.42
P/IV2.34
Premium +151%
Return to IV: -60.2%
PDC
Valuation N/A
Perpetuals.com Ltd
Price$3.25
Model IV—
P/IV—
Market implies +42.3%/yr
PDCC
Valuation N/A
Pearl Diver Credit Co Inc.
Price$7.95
Model IV—
P/IV—
Limited data — see page
PDEX
Deeply overvalued
PRO DEX INC
Price$62.49
Model IV$44.41
P/IV1.46
Premium +41%
Return to IV: -28.9%
Market implies -0.6%/yr
vs model +15.0% · below model
PDO
Valuation N/A
PIMCO Dynamic Income Opportunities Fund
Price$12.10
Model IV—
P/IV—
Limited data — see page
PDPA
Valuation N/A
Pearl Diver Credit Co Inc.
Price$24.98
Model IV—
P/IV—
Limited data — see page
PDSB
Valuation N/A
PDS Biotechnology Corp
Price$1.38
Model IV—
P/IV—
Limited data — see page
PDT
Valuation N/A
JOHN HANCOCK PREMIUM DIVIDEND FUND
Price$12.04
Model IV—
P/IV—
Limited data — see page
PDX
Valuation N/A
PIMCO Dynamic Income Strategy Fund
Price$20.83
Model IV—
P/IV—
Limited data — see page
PDYN
Valuation N/A
Palladyne AI Corp.
Price$5.04
Model IV—
P/IV—
Market implies +74.8%/yr
PDYNW
Valuation N/A
Palladyne AI Corp.
Price$0.00
Model IV—
P/IV—
Market implies -50.0%/yr
PEBK
Deeply overvalued
PEOPLES BANCORP OF NORTH CAROLINA INC
Price$43.78
Model IV$32.87
P/IV1.28
Premium +33%
Return to IV: -24.9%
PED
Deeply undervalued
PEDEVCO CORP
Price$13.47
Model IV$20.64
P/IV0.64
Discount 35%
Return to IV: +53.2%
Market implies -2.7%/yr
vs model +7.5% · below model
PEO
Valuation N/A
ADAMS NATURAL RESOURCES FUND, INC.
Price$28.86
Model IV—
P/IV—
Limited data — see page
PEPG
Valuation N/A
PepGen Inc.
Price$2.62
Model IV—
P/IV—
Limited data — see page
PERF
Fairly valued
Perfect Corp.
Price$1.92
Model IV$1.79
P/IV1.07
Premium +7%
Return to IV: -6.6%
Market implies +8.8%/yr
vs model +12.6% · below model
PESI
Valuation N/A
PERMA FIX ENVIRONMENTAL SERVICES INC
Price$13.76
Model IV—
P/IV—
Limited data — see page
PETS
Deeply undervalued
PETMED EXPRESS INC
Price$1.29
Model IV$4.95
P/IV0.44
Discount 74%
Return to IV: +285.2%
Market implies -28.1%/yr
vs model +2.0% · below model
PETZ
Valuation N/A
TDH Holdings, Inc.
Price$1.26
Model IV—
P/IV—
Market implies +26.2%/yr
vs model +3.7% · above model
PEW
Undervalued
GrabAGun Digital Holdings Inc.
Price$1.86
Model IV$2.61
P/IV0.83
Discount 29%
Return to IV: +40.3%
Market implies -6.3%/yr
vs model +15.0% · below model
PFAI
Valuation N/A
Pinnacle Food Group Ltd
Price$3.05
Model IV—
P/IV—
Market implies +57.0%/yr
vs model +8.0% · above model
PFBC
Valuation N/A
Preferred Bank
Price$102.58
Model IV—
P/IV—
Limited data — see page
PFD
Valuation N/A
FLAHERTY & CRUMRINE PREFERRED & INCOME FUND INC
Price$10.58
Model IV—
P/IV—
Limited data — see page
PFL
Valuation N/A
PIMCO INCOME STRATEGY FUND
Price$6.94
Model IV—
P/IV—
Limited data — see page
PFN
Valuation N/A
PIMCO Income Strategy Fund II
Price$6.25
Model IV—
P/IV—
Limited data — see page
PFO
Valuation N/A
Flaherty & Crumrine PREFERRED & INCOME OPPORTUNITY FUND INC
Price$8.56
Model IV—
P/IV—
Limited data — see page
PFSA
Valuation N/A
Profusa, Inc.
Price$1.42
Model IV—
P/IV—
Market implies +16.2%/yr
PFX
Valuation N/A
PhenixFIN Corp
Price$44.95
Model IV—
P/IV—
Limited data — see page
PFXNZ
Valuation N/A
PhenixFIN Corp
Price$24.07
Model IV—
P/IV—
Limited data — see page
PGAC
Valuation N/A
PANTAGES CAPITAL ACQUISITION Corp
Price$10.77
Model IV—
P/IV—
Limited data — see page
PGACR
Valuation N/A
PANTAGES CAPITAL ACQUISITION Corp
Price$0.19
Model IV—
P/IV—
Limited data — see page
PGACU
Valuation N/A
PANTAGES CAPITAL ACQUISITION Corp
Price$10.89
Model IV—
P/IV—
Limited data — see page
PGP
Valuation N/A
PIMCO Global StocksPLUS & Income Fund
Price$8.25
Model IV—
P/IV—
Limited data — see page
PGZ
Valuation N/A
Principal Real Estate Income Fund
Price$8.90
Model IV—
P/IV—
Limited data — see page
PHGE
Valuation N/A
BiomX Inc.
Price$0.29
Model IV—
P/IV—
Limited data — see page
PHIO
Valuation N/A
Phio Pharmaceuticals Corp.
Price$0.98
Model IV—
P/IV—
Limited data — see page
PHK
Valuation N/A
PIMCO HIGH INCOME FUND
Price$4.16
Model IV—
P/IV—
Limited data — see page
PHUN
Valuation N/A
Phunware, Inc.
Price$2.11
Model IV—
P/IV—
Market implies +77.3%/yr
vs model +2.0% · above model
PIII
Valuation N/A
P3 Health Partners Inc.
Price$4.95
Model IV—
P/IV—
Market implies -50.0%/yr
vs model +26.0% · below model
PIIIW
Valuation N/A
P3 Health Partners Inc.
Price$0.01
Model IV—
P/IV—
Market implies -50.0%/yr
vs model +26.0% · below model
PINE
Deeply overvalued
Alpine Income Property Trust, Inc.
Price$17.92
Model IV$11.42
P/IV1.48
Premium +57%
Return to IV: -36.3%
PJT
Valuation N/A
PJT Partners Inc.
Price$137.28
Model IV—
P/IV—
Limited data — see page
PLAG
Valuation N/A
Planet Green Holdings Corp.
Price$0.71
Model IV—
P/IV—
Market implies +27.7%/yr
vs model +2.0% · above model
PLBY
Deeply overvalued
Playboy, Inc.
Price$0.98
Model IV$0.53
P/IV2.60
Premium +86%
Return to IV: -46.4%
Market implies +8.0%/yr
vs model +2.0% · above model
PLCE
Valuation N/A
Childrens Place, Inc.
Price$1.42
Model IV—
P/IV—
Market implies -50.0%/yr
vs model +2.0% · below model
PLG
Valuation N/A
PLATINUM GROUP METALS LTD
Price$1.29
Model IV—
P/IV—
Market implies +46.7%/yr
vs model +5.0% · above model
PLMK
Valuation N/A
Plum Acquisition Corp, IV
Price$10.64
Model IV—
P/IV—
Limited data — see page
PLMKU
Valuation N/A
Plum Acquisition Corp, IV
Price$10.76
Model IV—
P/IV—
Limited data — see page
PLMKW
Valuation N/A
Plum Acquisition Corp, IV
Price$0.40
Model IV—
P/IV—
Limited data — see page
PLRX
Valuation N/A
PLIANT THERAPEUTICS, INC.
Price$1.02
Model IV—
P/IV—
Market implies +46.3%/yr
vs model +15.0% · above model
PLRZ
Valuation N/A
Polyrizon Ltd.
Price$8.99
Model IV—
P/IV—
Limited data — see page
PLSM
Valuation N/A
Pulsenmore Ltd.
Price$1.85
Model IV—
P/IV—
Limited data — see page
PLTM
Valuation N/A
GraniteShares Platinum Trust
Price$16.18
Model IV—
P/IV—
Limited data — see page
PLTS
Valuation N/A
Platinum Analytics Cayman Ltd
Price$17.50
Model IV—
P/IV—
Market implies +31.2%/yr
PLUR
Valuation N/A
Pluri Inc.
Price$0.95
Model IV—
P/IV—
Market implies +12.5%/yr
vs model +15.0% · in line
PLUT
Valuation N/A
Plutus Financial Group Ltd
Price$2.07
Model IV—
P/IV—
Market implies +31.8%/yr
PLX
Valuation N/A
Protalix BioTherapeutics, Inc.
Price$2.78
Model IV—
P/IV—
Market implies +18.3%/yr
PLYX
Valuation N/A
Polaryx Therapeutics, Inc.
Price$2.00
Model IV—
P/IV—
Limited data — see page
PMAX
Deeply overvalued
Powell Max Ltd
Price$0.69
Model IV$0.20
P/IV4.51
Premium +241%
Return to IV: -70.6%
Market implies +20.7%/yr
vs model +15.0% · above model
PMCB
Valuation N/A
PharmaCyte Biotech, Inc.
Price$0.40
Model IV—
P/IV—
Limited data — see page
